Stanislav Plutizki
Fondateur chez GeneQuine Biotherapeutics GmbH
Profil
Stanislav Plutizki is the founder and has held the title of Vice President-Regulatory & Medical Affairs at GeneQuine Biotherapeutics GmbH since 2012.
He received his undergraduate and doctorate degrees from The Johannes Gutenberg University of Mainz.
Postes actifs de Stanislav Plutizki
| Sociétés | Poste | Début |
|---|---|---|
GeneQuine Biotherapeutics GmbH
 GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology GeneQuine Biotherapeutics GmbH develops gene therapy drugs for the treatment of osteoarthritis. Its gene therapy is to introduce genetic material into the patient's own cells in the body. The firm's genetic material will make the cells to produce a therapeutic protein. The company was founded by Kilian Guse and Stanislav Plutizki in October 2012 and is headquartered in Hamburg, Germany. | Fondateur | 01/10/2012 |
Formation de Stanislav Plutizki
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
GeneQuine Biotherapeutics GmbH
GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology GeneQuine Biotherapeutics GmbH develops gene therapy drugs for the treatment of osteoarthritis. Its gene therapy is to introduce genetic material into the patient's own cells in the body. The firm's genetic material will make the cells to produce a therapeutic protein. The company was founded by Kilian Guse and Stanislav Plutizki in October 2012 and is headquartered in Hamburg, Germany. | Health Technology |
